Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches.
Get an overview of different cancer types and how recent advances may affect clinical decision making and treatment of these cancers.
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Explore the different materials that Boehringer Ingelheim presented at recent oncology congresses.
Something great is on the way
